Literature DB >> 2167336

Susceptibility of human herpesvirus 6 to antivirals in vitro.

W H Burns1, G R Sandford.   

Abstract

Human herpesvirus 6 (HHV-6) is a recently recognized human herpesvirus isolated from lymphoid cells and thought to be the causative agent for exanthem subitum. Using dot blot hybridization, the HHV-6 sensitivity pattern to several antivirals was compared with those of herpes simplex virus type 1 and human cytomegalovirus. HHV-6 most closely resembled cytomegalovirus in that it was relatively resistant to the antiviral effects of acyclovir and bromovinyl-deoxyuridine but sensitive to ganciclovir and phosphonoacetic acid. From these results, it appears more likely that HHV-6 infections would respond to ganciclovir and foscarnet than to acyclovir should treatment be deemed advisable, although the low toxicity of acyclovir may allow for its use at doses that might affect replication of HHV-6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167336     DOI: 10.1093/infdis/162.3.634

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report.

Authors:  Kelly Baldwin
Journal:  J Neurovirol       Date:  2011-02-02       Impact factor: 2.643

Review 3.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.

Authors:  Nahid Akhyani; Julie Fotheringham; Karen Yao; Farzin Rashti; Steven Jacobson
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

5.  Analysis of ganciclovir-resistant human herpesvirus 6B clinical isolates using quenching probe PCR methodology.

Authors:  Hiroyuki Hiramatsu; Ryota Suzuki; Shigeki Yamada; Masaru Ihira; Yuji Isegawa; Yoshiki Kawamura; Erina Matsuoka; Hiroki Miura; Tetsushi Yoshikawa
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

6.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

Review 7.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

8.  Characterization of the DNA polymerase gene of human herpesvirus 6.

Authors:  I A Teo; B E Griffin; M D Jones
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

10.  Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience.

Authors:  Tomasz Dzieciatkowski; Maciej Przybylski; Tigran Torosian; Agnieszka Tomaszewska; Mirosław Luczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.